Recent Blog Posts

View Post: Current Research into a Cure for Type-1 Diabetes: Wilson's ...
20 Oct 2009 by Joshua Levy  
Pioglitazone has been approved for use in type-2 diabetes for about 10 years. Pioglitazone is part of a larger drug family called thiazolidinediones which have been shown to preserve beta cells in animals with type-1 diabetes, ...
View Blog: Current Research into a Cure for Type-1 Diabetes - http://cureresearch4type1diabetes.blogspot.com/

---

View Post: Pioglitazone Stimulates Apolipoprotein A-I Production Without ...
17 Oct 2007 by Qin, S., Liu, T., Kamanna, VS, Kashyap, ML  
Objective— Pioglitazone, an antihyperglycemic drug, increases plasma high-density lipoprotein (HDL)-cholesterol in patients with type 2 diabetes. The mechanisms by which pioglitazone regulate HDL levels are not clear. ...
View Blog: ATVBe First - http://atvb.ahajournals.org/

---

View Post: Impaired insulin-stimulated phosphorylation of Akt and AS160 in ...
31 Oct 2007 by Hojlund, K., Glintborg, D., Andersen, N....  
Objective: Insulin resistance in skeletal muscle is a major risk factor for type 2 diabetes in women with polycystic ovary syndrome (PCOS). However, the molecular mechanisms underlying skeletal muscle insulin resistance and the ... Importantly, the pioglitazone-mediated improvement in insulin-stimulated glucose metabolism, which did not fully reach normal levels, was accompanied by normalization of insulin-mediated Akt phosphorylation at Ser473 and Thr308 and AS160 ...
View Blog: Diabetes Journal publish ahead of print articles - http://diabetes.diabetesjournals.org/

---

View Post: Earlier triple therapy with pioglitazone in patients with ...
16 Sep 2009
Recent findings from a French randomised controlled study suggest that patients with type 2 diabetes, who are not well controlled with dual combination therapy, may benefit from earlier triple therapy with pioglitazone. ...
View Blog: NeLM - News - http://www.nelm.nhs.uk/en/NeLM-Area/News/

---

View Post: Nonalcoholic Steatohepatitis Clinical Trial: University of Texas ...
12 Oct 2009
After all patients receive dietary counseling at the research unit (CTSA), patients with type 2 diabetes mellitus (T2DM) and NASH will be started on pioglitazone (or placebo) in a randomized, double-blind,placebo-controlled study design ...
View Blog: Clinical Trials Updates During the Last 7 Days - http://clinicaltrialsfeeds.org/clinical-trials/r...

---

View Post: Pills for Type 2 Diabetes - AHRQ Effective Health Care Program ...
5 Dec 2007 by Effective Health Care - Agency for Healthcare...  
Swelling. Pioglitazone (Actos®) and rosiglitazone (Avandia®) are more likely to cause water retention than other diabetes pills. If you get swelling in your face or legs, it might be from water retention. Tell your doctor or nurse. ...
View Blog: Effective Health Care - http://effectivehealthcare.ahrq.gov/

---

View Post: Comparable HbA1c reduction seen with INT-131 and pioglitazone in ...
6 Oct 2009
The results of a phase IIb study showed similar efficacy but superior safety with INT-131 compared to pioglitazone hydrochloride (Takeda, Novo Nordisk, Lilly) in patients with type 2 diabetes. The study enrolled 366 patients who were ...
View Blog: Breaking News - Diabetes Pro (American... - http://www.diabetes.org/pro/

---

View Post: November is American Diabetes Month! – Institute for Women's ...
2 Nov 2009 by Michelle Desjardins  
Recently he published a study in Obesity examining various lifestyle interventions for prevention of weight gain in type II diabetic patients taking the common diabetes medication pioglitazone (Actos®). The study showed that the weight ...
View Blog: Institute for Women's Health Research Blog... - http://blog.womenshealth.northwestern.edu/

---